Glaucoma

Følg
Researchers at the University of Missouri in a lab studying agmatine and thiamine as biomarkers for early glaucoma detection, with vials and eye scans visible.
Bilde generert av AI

Mizzou researchers identify molecules for early glaucoma detection

Rapportert av AI Bilde generert av AI Faktasjekket

Scientists at the University of Missouri report that two natural molecules — agmatine and thiamine — are reduced in samples from glaucoma patients and could serve as early biomarkers. In preclinical work, the compounds also showed signs of protecting retinal cells, suggesting a path to earlier detection and potential neuroprotective therapies.

Dette nettstedet bruker informasjonskapsler

Vi bruker informasjonskapsler for analyse for å forbedre nettstedet vårt. Les vår personvernerklæring for mer informasjon.
Avvis